Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 1.14.14.47 extracted from

  • Holden, J.K.; Dejam, D.; Lewis, M.C.; Huang, H.; Kang, S.; Jing, Q.; Xue, F.; Silverman, R.B.; Poulos, T.L.
    Inhibitor bound crystal structures of bacterial nitric oxide synthase (2015), Biochemistry, 54, 4075-4082.
    View publication on PubMedView publication on EuropePMC

Cloned(Commentary)

Cloned (Comment) Organism
-
Bacillus subtilis

Crystallization (Commentary)

Crystallization (Comment) Organism
in complex with a number of inhibitors Bacillus subtilis

Protein Variants

Protein Variants Comment Organism
E25A/E26A/E316A mutant facilitates crystallization Bacillus subtilis
E25A/E26A/E316A/Y357F mutant facilitates crystallization Bacillus subtilis

Inhibitors

Inhibitors Comment Organism Structure
3-[2,4-di(6-amino-4-methylpyridin-2-yl)ethyl]benzonitrile inhibitor binds to heme propionate A through a bifurcated H-bond and a pi-pi stacking interaction between the conserved Tyr and aminopyridine group Bacillus subtilis
6-[5-([4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl]oxy)pentyl]-4-methylpyridin-2-amine binding is stabilized by a 3.2 A H-bond between the pyrrolidine ring and the carbonyl group of tetrahydrobiopterin Bacillus subtilis
N,N'-[[(2S)-3-aminopropane-1,2-diyl]bis(oxymethylene-3,1-phenylene)]di(thiophene-2-carboximidamide) inhibitor binds by extending outside the active site to interact with a surface adjacent to residue Y357 Bacillus subtilis
N1-[6-[2-(6-amino-4-methylpyridin-2-yl)ethyl]pyridin-2-yl]-N1,N2-dimethylethane-1,2-diamine inhibitor binding distorts the pterin binding site by inducing an alternative rotameric position in residue W329. KS value 18.3 microM Bacillus subtilis

Organism

Organism UniProt Comment Textmining
Bacillus subtilis O34453
-
-
Bacillus subtilis 168 O34453
-
-